international
EU hits France's Sanofi with flu vaccine antitrust probe
Why this matters: an international story with cross-border implications worth tracking.
The investigation centers on how the firm marketed an enhanced flu vaccine, offered under the brand name Efluelda and designed to provide greater protection for people over 60.
Read full story on Le Monde (English) → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Le Monde (English) alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop